The difference between lorlatinib and lorlatinib
Lorlatinib and lorlatinib are the same medicine, they just have different names. Lorlatinib is a novel, highly potent, brain-penetrating, third-generation ALK/ROS1 tyrosine kinase inhibitor (TKI) with broad-spectrum efficacy against most known resistance mutations that may be associated with the use of crizotinib and second-generation ALK Occurring during treatment with TKIslorlatinib is used to treat adult patients with metastatic non-small cell lung cancer(NSCLC).

The recommended dose of lorlatinib is 100 mg orally once daily. Patients with severe renal impairment: 75 mg orally once daily. Sometimes it is unsafe to use certain drugs together. Some drugs can affect the blood levels of other drugs the patient is taking, which may increase side effects or make the drugs less effective. Many drugs can interact with loratinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Larlatinibcan harm an unborn baby or cause birth defects. Ifthe patientis female and pregnant, please do not uselorlatinib. Before starting this treatment, patients may need to have a negative pregnancy test and use effective birth control to prevent pregnancy while taking this medication and for at least 6 months after the last dose. If the patient is male and if your sexual partner can become pregnant, please take effective contraceptive measures and continue to use birth control pills for at least 3 months after the last dose. Lorlatinib may affect male fertility, however, it is important to use birth control to prevent pregnancy because Lorlatinib can harm an unborn baby. Larlatinib can reduce the effectiveness of hormonal birth control (Birth control injections, implants, skin patches, vaginal rings). Consult your doctor about the best method of contraception to use during treatment with this drug. Do not breastfeed while using lorlatinib for at least 7 days after the last dose. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.
xa0
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)